🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham - Main /ID# 261434
Start Date
2024-05-19
Trial ID
NCT06158841
Treatments Being Tested
This study will evaluate the effect of food and smoking on healthy older su...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2014-05-30
Trial ID
NCT02168205
Treatments Being Tested
The purpose of this study is to see if the study drug, called Vactosertib, ...
Status
Completed
Location
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2017-07-21
Trial ID
NCT03143985
Treatments Being Tested
Primary Objective: To demonstrate the benefit of isatuximab in combination...
Status
Completed
Location
BRCR Medical Center Inc. Site Number : 8400002
Start Date
2016-12-22
Trial ID
NCT02990338
Treatments Being Tested
This study is researching an experimental drug called linvoseltamab, also c...
Status
Recruiting
Location
University of California Los Angeles (UCLA)
Start Date
2023-09-18
Trial ID
NCT05730036
Treatments Being Tested
Belantamab mafodotin (GSK2857916) is a first in class, antibody dependent c...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-03-14
Trial ID
NCT03828292
Treatments Being Tested
Primary Purpose Phase Ib. To determine the Maximum Tolerated Dose (MTD) and...
Status
Recruiting
Location
West China Hospital Sichuan University
Start Date
2024-03-25
Trial ID
NCT06484829
Treatments Being Tested
The purpose of this study is to evaluate how well IBI3003 works when compar...
Status
Not Yet Recruiting
Location
ZhongShan Hospital FuDan University
Start Date
2026-06-05
Trial ID
NCT07623798
Multiple myeloma (MM) accounts for more than 10% of all blood cancers and 1...
Status
Terminated
Location
Sylvester Comprehensive Cancer Center /ID# 228817
Start Date
2022-01-17
Trial ID
NCT04895410
Treatments Being Tested